Our companies:
Fishawack Communications



  • Specialist medical communications agency providing professional services to assist large global pharmaceutical companies in educating the medical sector on pharmaceutical products that are in mid to late stage clinical trials and also supporting these products post market launch
  • The business was founded in 2001 by the current CEO, Oliver Dennis and CFO, Dominic Miller
  • The business now employs over 160 people with operations in UK, Switzerland and the US


Key facts

Sector: Healthcare
Location: Manchester, Oxford, Basel, Philadelphia (US), Basel and Zofingen (Switzerland)
Status: Realised
Website: www.fishawack.com
Follow on Twitter: @Fishawack

Why we invested:


  • Historically Fishawack had grown successfully both organically and through acquisition to become a full service medical communications agency working on global accounts for large pharmaceutical clients such as GSK, Sanofi and Novartis
  • The business provides a highly valued added service delivered by a professional workforce with high levels of scientific expertise
  • Opportunity to support the buy and build opportunity

The deal

Size at investment: £13m
Bought from: YFM Equity Partners
Date of investment: March 2013
Deal type: Secondary MBO

How we made a difference:


  • GCP underwrote the entire transaction, providing the debt and equity on the deal
  • GCP funding and hands on M&A support played a key role in executing three strategic bolt-on acquisitions: Archimed, JK Associates Inc and Facilitate Limited
  • Following the integration of three strategic acquisitions and strong organic growth across the top 20 pharmaceutical clients, the earnings of the group more than doubled
  • With this increased scale an opportune time arose to realise value for Fund III whilst achieving the management objective of continuing a larger buy and build programme
  • GCP completed the successful sale of Fishawack Group Limited on Friday 20th January


“GCP has a very strong track record of helping businesses deliver on their growth plans.”

Oliver Dennis, Co-founder of Fishawack

Exit result

SIZE: : £38m
DATE OF EXIT:: January 2017